Generali Asset Management’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.72M Buy
15,070
+2,655
+21% +$1.25M 0.12% 158
2026
Q1
$4.92M Sell
12,415
-171
-1% -$77.3K 0.1% 186
2025
Q4
$5.91M Buy
12,586
+275
+2% +$122K 0.12% 160
2025
Q3
$6.07M Sell
12,311
-2,594
-17% -$1.47M 0.13% 147
2025
Q2
$7.64M Sell
14,905
-1,973
-12% -$919K 0.17% 121
2025
Q1
$7.24M Buy
16,878
+6,187
+58% +$3.01M 0.18% 121
2024
Q4
$5.19M Buy
+10,691
New +$5.59M 0.13% 156

Other funds holding SNPS

Generali Asset Management's SNPS Position: Q2 2026 in Review

Generali Asset Management increased its Synopsys (SNPS) stake by 21% in Q2 2026, buying an estimated $1.25M and bringing the position to 15,070 shares worth $6.72M. The position accounts for 0.12% of the portfolio, ranked #158.

Generali Asset Management first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.64M in Q2 2025. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Generali Asset Management held 15,070 shares of Synopsys worth $6.72M as of Q2 2026.
  • Generali Asset Management bought 2,655 Synopsys shares in Q2 2026, an estimated $1.25M.
  • Synopsys made up 0.12% of Generali Asset Management's portfolio in Q2 2026, its #158 holding.
  • Generali Asset Management first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Synopsys position peaked at $7.64M in Q2 2025.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.